Clinical Trial Update: SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin [Phase 1]

View source ↗

Summary

GlaxoSmithKline completed a Phase 1 bioequivalence study of SECOTEX (tamsulosin hydrochloride) in Brazil, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Secotex

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 1 | Status: COMPLETED | Results posted: 2011-04-06